CD4+ T cells remained unchanged, while CD8+ T cells reduced significantly in stress group at 1 week compared with that of the control group, but remained comparable between the two groups at 2 weeks with a decreased trend along with the progression of the cancer. The gene discussed is CD8A; the disease is cancer.